Neoadjuvant FDC With Melatonin or Metformin for Locally Advanced Breast Cancer.

NCT02506777 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

96

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: metformin
DRUG: Fluoruracil
DRUG: Doxorubicin
DRUG: Cyclophosphamide
DRUG: melatonin

Sponsor

N.N. Petrov National Medical Research Center of Oncology